Frank W. Chan's most recent trade in Haemonetics Corp. was a trade of 12,317 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp. | Frank W. Chan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 12,317 | 12,317 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Frank W. Chan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 5,689 | 5,689 (0%) | 0% | - | Common Stock |